Medical Updates & Immunization Site Training for All Healthcare Providers led by Pfizer Vaccines US Medical Affairs

Goal:  Educate providers and immunization staff personnel on the proper use of the Pfizer-BioNTech COVID-19 Vaccines

Session Topics Include:

• Emergency Use Authorization of the Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5) as a single booster dose for individuals 5 years of age and older
  • Limited introduction of the Gray Cap Pfizer-BioNTech COVID-19 Vaccine, Bivalent for individuals 12 years of age and older in single dose vials
• Use of currently authorized vaccines, including storage, handling, preparation, and administration
• Question and answer session

Sessions will be updated to reflect the latest information.

Join the sessions at the designated times listed below:

Schedule through December 2022*. Please check back for future training session information.

*Dates subject to change

Continuing medical education is NOT associated with this event

Emergency uses of the vaccines have not been approved or licensed by FDA, but have been authorized by FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) in individuals aged 6 months and older for the Pfizer-BioNTech COVID-19 Vaccine and 5 years and older for the Pfizer-BioNTech COVID-19 Vaccine, Bivalent. The emergency uses are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564(b)(1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner.

Before administration, please see full Prescribing Information: 12 years of age and older or appropriate EUA Fact Sheet for Vaccination Providers. For the most recent prescribing information and fact sheets, please visit www.cvdvaccine-us.com